Table 1

Characteristics of those who attended the initial assessment (IA)

CVD (n=1268) HRI (n=1943)
Mean age (SD)64.5 (12.2)62.9 (19.5)
Male: n (%)929 (73.5)1102 (56.7)
Ethnicity: n (%)
White
Arab
Afro Caribbean
South Asian
Other
558 (44.2)
154 (12.2)
86 (6.8)
194 (15.4)
270 (21.4)
979 (50.6)
162 (8.4)
160 (8.3)
225 (11.6)
409 (21.1)
Diagnostic category: n (%)
Coronary heart disease
Cerebrovascular disease
Peripheral arterial disease
Diabetes mellitus type II
Valve disease
High CVD risk
Moderate/low CVD risk
1151 (90.8)
67 (5.3)
50 (3.9)






228 (11.7)
77 (4.0)
1352 (69.6)
286 (14.7)
Current smoking (%)12.620.4
Body mass index: kg/m2 mean (SD)28.3 (5.3)30.1 (5.9)
Mediterranean diet score: mean (SD)7.2 (2.2)7.1 (2.2)
Achieving physical-activity targets (%)12.622.0
Blood pressure: mm Hg; mean (SD)130.6 (20.1)/73.5 (10.7)137.8 (17.4)/81.1 (10.4)
Total cholesterol, mmol/L, mean (SD)4.0 (1.2)5.2 (1.2)
LDL-cholesterol, mmol/L, mean (SD)2.2 (0.9)3.2 (1.0)
Statins (%)91.140.7
Antiplatelets (%)90.914.9
ACE inhibitors/ARBs (%)69.135.3
Anxiety score: median (IQR)6 (3–10)5 (2–9)
Depression score median (IQR)5 (2–8)3 (1–7)
EuroQol Visual Analogue Scale median (IQR)60 (45–75)70 (50–80)
Dartmouth COOP median (IQR)24 (19–29)21 (17–27)
  • ARBs, angiotensin receptor blockers; CVD, cardiovascular disease; HRI, high multifactorial risk; LDL, low-density lipoprotein.